Back to top

Kirin Holdings: Promising Health Science Growth Amidst Pharmaceutical Challenges, Hold Rating Maintained

DBS analyst Zheng Feng Chee has maintained their neutral stance on KNBWF stock, giving a Hold rating on May 13. Zheng Feng Chee’s rating is based o...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kirin Holdings Co. (KNBWY)